FDA Announces Federal Regulations of E-Cigarettes

In a move that’s been building for nearly two years, the U.S. Food and Drug Administration (FDA) announced on May 5, 2016, that it will now federally regulate e-cigarettes in much the same way that it regulates the tobacco industry.

Immunotherapy Is Changing the Future of Cancer Care

Today, the focus of many groundbreaking cancer therapies has turned inward—to the body’s own immune system. Although using the immune system to fight cancer isn’t a new theory, huge advances in the field of immunotherapy have started to change the landscape of cancer treatment as we know it.

Jeanie Rosiak

Our Work to Define the Elusive Optimal Staffing Levels

A question often posed to the ONS clinical inquiries inbox is what ONS recommends for staffing in inpatient cancer units or chemotherapy treatment centers. This question is asked by members, nonmembers, and non-nurse practice administrators. Our colleagues at the Association of Community Cancer Centers also see their members raise this topic, and it’s not unique to oncology nursing.

What’s in Store for the Future of Immunotherapy?

There are exciting developments in the field of immunotherapy today. We are seeing much higher response rates with some of the newer forms of immunotherapy, and it seems to work in many different types of cancer.

June 2016 Feature

June 2016

Unbranded Test

This is some unbranded content.

Oncology Nurses Have Important Roles in Clinical Trial Access and Enrollment

When President Obama announced the National Cancer Moonshot Initiative during his State of the Union address in January 2016, he set lofty goals for oncology professionals. One of those goals called for increased access to and participation in clinical trials. Clinical trial data are integral in getting cutting-edge treatments to market, where they can help improve cancer care. However, many patients aren’t fully educated about the efficacy of these new forms of treatment and what these trials entail.

Apply for the ONS Seal of Approval

Check back soon for more information.